SUBSCRIBERS
QT Vascular balloons on clinical trial update
Published Wed, Jan 7, 2015 · 09:50 PM
Singapore
SHARES in QT Vascular, a developer and manufacturer of medical devices for the treatment of vascular diseases, jumped as much as 12.5 per cent to 36 Singapore cents on Wednesday, after a Tuesday night update on enrolment for its clinical trial of a product.
The stock ended the day at 35.5 Singapore cents, still 3.5 cents or 10.9 per cent up from the previous closing, after 14.8 million shares changed hands.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Asia markets mixed after Fed leaves rates unchanged; STI rises 0.1%
Singapore Savings Bond 10-year average yield hits year-to-date high of 3.33%
Universal Music Group reaches new licensing agreement with TikTok
Sumitomo to bolster shareholder returns in new mid-term plan
US Fed ‘less hawkish’ than expected; Singapore banks, net cash companies likely to outperform
ST Engineering bags more than S$175 million in contracts to upgrade Singapore’s public bus fleet